Endologix, trading OTCMKTS under the symbol ELGXQ, is a medical device company specializing in minimally invasive therapies for the treatment of abdominal aortic aneurysms (AAA). The company develops, manufactures and markets a portfolio of endovascular stent-graft systems designed to repair and reinforce weakened sections of the aorta. Its product lineup has historically included the Powerlink®, AFX®, and Nellix® endovascular systems, as well as the Ovation® platform, all engineered to offer precision sizing, conformability and secure sealing for a range of aneurysm anatomies.
Founded in the early 1990s and headquartered in Irvine, California, Endologix has focused on advancing endovascular solutions as an alternative to open surgical repair. The company’s research and development efforts aim to improve patient outcomes by reducing procedural complexity, shortening hospital stays and minimizing perioperative risks. Clinical studies and real-world experience have supported the safety and efficacy of its devices, driving adoption among vascular surgeons and interventionists in hospitals and specialty clinics.
Endologix markets its products globally, with distribution channels and regulatory approvals across North America, Europe and select international markets. The company has historically maintained a network of direct sales representatives, distributors and strategic partners to support product training, procedural planning and ongoing clinical education. This geographic reach enables Endologix to address the growing prevalence of AAA in aging populations worldwide.
Throughout its history, Endologix has evolved through product innovations, regulatory milestones and strategic collaborations. By concentrating exclusively on endovascular aneurysm repair, the company seeks to differentiate itself in the competitive vascular device arena. Its continuing R&D initiatives underscore a commitment to next-generation technologies that streamline procedural workflows and expand patient eligibility for minimally invasive AAA treatments.
AI Generated. May Contain Errors.
Free ELGXQ Stock Alerts